Invention Grant
- Patent Title: Anti-epidermal growth factor receptor antibodies and uses thereof
- Patent Title (中): 抗表皮生长因子受体抗体及其用途
-
Application No.: US13509235Application Date: 2009-12-30
-
Publication No.: US08653244B2Publication Date: 2014-02-18
- Inventor: David Weaver , Michael Rynkiewicz , Cheng Cao , Yanwen Jin
- Applicant: David Weaver , Michael Rynkiewicz , Cheng Cao , Yanwen Jin
- Applicant Address: CN Guangdong Province
- Assignee: Guangzhou Yunyuan Biotech Co., Ltd.
- Current Assignee: Guangzhou Yunyuan Biotech Co., Ltd.
- Current Assignee Address: CN Guangdong Province
- Agency: Knobbe Martens Olson & Bear, LLP
- Priority: CN200910237804 20091111
- International Application: PCT/CN2009/001605 WO 20091230
- International Announcement: WO2011/057436 WO 20110519
- Main IPC: C07K16/00
- IPC: C07K16/00 ; A61K39/395
Abstract:
The present invention discloses humanized anti-epidermal growth factor receptor antibodies, which have favorable binding activity (the binding affinity being 6.13×10−10 mol/L) and are able to inhibit the growth and migration of tumor cells. The present invention also discloses the preparation methods and uses of the antibodies.
Public/Granted literature
- US20120321643A1 ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND USES THEREOF Public/Granted day:2012-12-20
Information query
